| abstract |
REFERS TO AN ORAL COMPOSITION OF CONTROLLED RELEASE OF AN OPIOID ANALGESIC SUCH AS OXICODON, MORPHINE, LEVORPHANOL, METHADONE, DIHYDROCODEINE, CODEINE, DIHYDROMORPHINE, PETIDINE, PYRITRAMIDE, FENTANIL DEPRENADOLINE 1000 mg, BUTERACHYL DYLLIDINE 1000 mg, CARCHETHYLLIDEDINE IT IS PRESENTED IN THE FORM OF CRYSTALS WITH A GRANULOMETRY OF 10 µm TO 3 mm, BEING MONOCRISTALS OR WITH A POLYCHRYSTALLINE STRUCTURE, THE CRYSTALS MAY BE COMPRESSED IN THE FORM OF TABLETS WITH AUXILIARIES AND ADDITIVES CONVENTIONAL COMPROMISES THAT HAVE A RETAIL 30 RETURNS AT LEAST 30 RETURNS % by weight of a polymer is not RETARDANTE resins ACRILICAS, cellulose derivatives (ethyl cellulose, acrylic acid, polymethacrylic up to 30% by weight hydroxypropyl cellulose, hydroxymethyl cellulose, hydroxypropyl methyl cellulose, povidone AND OTHER coating consisting of a material other than COATING RETARDANTE APPLIED AS A NON-RETARDING SEPARATOR COAT FORM ON THE SURFACE OF THE CRYSTALS, RESISTANT TO GASTRIC JUICE; ALSO THE COATING CONTAINS ANALGESIC DIFFERENT FROM THE ANALGESIC OF CRYSTALS |